Premium
Letter: mesalazine—a safe drug with rare serious adverse events
Author(s) -
Scrivo Barbara,
Renna Sara,
Casà Angelo,
Monachino Noemi,
Macaluso Fabio S.,
Orlando Ambrogio
Publication year - 2020
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.15691
Subject(s) - medicine , mesalazine , drug , adverse effect , pharmacology , ulcerative colitis , disease